The authors suggested that hematopoietic TIPE2 regulated intestinal anti-tumor immunity by regulation of gut microbiota. TIPE2 may represent a new therapeutic target for treating colorectal cancer.
[Cancer Immunology Research]
Sorry, but the selected Zotpress account can't be found.